Compounded medications are tailored to individual needs and are not FDA-approved for safety or effectiveness
Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens
We are actively expanding exports into Central Africa (Cameroon, Chad, DRC, Gabon, Republic of Congo, Equatorial Guinea), Central America (Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama), CIS Countries (Russia, Kazakhstan, Uzbekistan, Armenia, Georgia, Kyrgyzstan, Tajikistan), and new markets including Sweden, Namibia, and Peru, with further plans to enter the Philippines, Nigeria
This makes the metabolic case for GLP-1 treatment stronger, not weaker, as men get older